YN320826 Veliflapon 128253-31-6

Veliflapon (BAY X 1005; DG-031) is an orally active and selective5-lipoxygenase activating protein (FLAP)inhibitor. Veliflapon inhibits the synthesis of theleukotrienes B4 and C4.

YN373864 Bivalirudin 128270-60-0

Bivalirudin Trifluoroacetate is a synthetic 20 residue peptide (thrombin inhibitor) which reversibly inhibits thrombin.

YN484271 Glycerol derivative 1 128400-55-5

Glycerol derivative 1 is a Glycerol derivative extracted from patent EP 672415 A1, compound (1).

YN321054 Arbutamine 128470-16-6

Arbutamine is a short-acting, potent and nonselectiveβ-adrenoceptoragonist that increases heart rate, cardiac contractility, and systolic blood pressure. Arbutamine is a catecholamine for a pharmacological cardiac stress agen.

YN482817 Ophiogenin 3-O-α-L-rhamnop... 128502-94-3

Ophiogenin 3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside, a terpenoid glycoside fromOphiopogon japonicusroots, has good pharmacological effects on the cardiovascular system.

YN321809 Rat CGRP-(8-37) 129121-73-9

Rat CGRP-(8-37) (VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF) is a highly selectiveCGRP receptorantagonist.

YN361023 Iberiotoxin 129203-60-7

Iberiotoxin is a toxin isolated fromButhus tamulusscorpion venom. Iberiotoxin is a selective high conductance high conductanceCa2+-activated K+channelinhibitor with aKdof ~1nM. Iberiotoxin does not block other types of voltage-depen...

YN484257 Anti-hypertensive sulfonanili... 129280-22-4

Anti-hypertensive sulfonanilide 1 is a potent antihypertensive agent extracted from patent EP0338793A2, compound XVIIIa,b*, example No.1.

YN370214 TNP-470 129298-91-5

TNP-470 is amethionine aminopeptidase-2inhibitor and also anangiogenesisinhibitor.

YN370975 Sampatrilat 129981-36-8

Sampatrilat (UK-81252) is a potent and orally activevasopeptidaseinhibitor ofACE and neutral endopeptidase (NEP). Sampatrilat inhibits C-domain ACE (Ki=13.8nM) 12.4-fold more potent than that for the N-domain (Ki=171.9n...

YN370122 NQ301 130089-98-4

NQ301 (compound 211), an antiplatelet and antithrombotic agent, is a selective CD45 inhibitor with IC50 of 200 nM. NQ301 inhibits thromboxane A2 receptor (TXA2) and synthase activity in rabbit platelets.

YN483983 C-Reactive Protein (CRP)... 130348-99-1

C-Reactive Protein (CRP) 201-206 is the 201-206 fragment of C-Reactive Protein. C-Reactive Protein (CRP), the prototypic marker of inflammation, is a cardiovascular risk marker and may promote atherogenesis.

YN483992 C-Reactive Protein (CRP)... 130349-01-8

C-Reactive Protein (CRP) 77-82 is the 77-82 fragment of C-Reactive Protein. C-Reactive Protein (CRP), the prototypic marker of inflammation, is a cardiovascular risk marker and may promote atherogenesis.

YN373999 Bimoclomol 130493-03-7

Bimoclomol is aheat shock protein (HSP)coinducer, used for treatment of cardiovascular diseases.

YN320221 PD 123319 130663-39-7

PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM.

YN484231 GP2-114 130783-39-0

GP2-114 (GP-2-114) produces current-dependent cardiovascular action when administered by transdermal iontophoresis.

YN320939 Fuscoside 131631-89-5

Fuscoside (OPC-21268) is an orally effective, nonpeptide,vasopressin V1receptor antagonist with an IC50 of 0.4μM.

YN360803 Ropivacaine hydrochloride mon... 132112-35-7

Ropivacaine HCl is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.

YN360619 Cilnidipine 132203-70-4

Cilnidipine is a unique L-type and N-type calcium channel blocker, used for high blood pressure treatment.

YN480149 Setipafant 132418-35-0

Setipafant is a platelet-activating factor (PAF) antagonist.